Carlsmed, Inc. SEC filings CARL
Carlsmed, Inc. has 97 filings in SEC EDGAR's recent list, going back to Nov 19, 2019. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 30, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Oct 1, 2026 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 30, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 8, 2026 | Sep 4, 2026 |
| EFFECT | Filing | Aug 21, 2026 | — |
| S-3 | Shelf registration | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2026 | Jun 3, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Jun 3, 2026 |
| S-8 | Employee stock plan registration | Feb 25, 2026 | — |
| 10-K | Annual report | Feb 25, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 25, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 12, 2026 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 30, 2025 | Oct 29, 2025 |
| 10-Q | Quarterly report | Aug 28, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 28, 2025 | Aug 28, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 24, 2025 | Jul 24, 2025 |
| S-8 | Employee stock plan registration | Jul 24, 2025 | — |
| 424B4 | Prospectus | Jul 24, 2025 | — |
| EFFECT | Filing | Jul 22, 2025 | — |
| CERT | Filing | Jul 22, 2025 | — |
| 8-A12B | Filing | Jul 21, 2025 | — |
| CORRESP | Letter to the SEC | Jul 18, 2025 | — |
| CORRESP | Letter to the SEC | Jul 18, 2025 | — |
| CORRESP | Letter to the SEC | Jul 15, 2025 | — |
| S-1/A | Amended registration statement | Jul 15, 2025 | — |
| CORRESP | Letter to the SEC | Jul 7, 2025 | — |
| S-1 | Registration statement | Jun 26, 2025 | — |
| CORRESP | Letter to the SEC | Jun 26, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2025 | — |
| DRSLTR | Filing | May 30, 2025 | — |
| DRS/A | Filing | May 30, 2025 | — |
| UPLOAD | Letter from the SEC | May 21, 2025 | — |
| DRS | Filing | Apr 24, 2025 | — |
| DRSLTR | Filing | Apr 23, 2025 | — |
| D/A | Filing | Feb 7, 2025 | — |
| D | Filing | Mar 21, 2024 | — |
| D | Filing | Apr 27, 2022 | — |
| D | Filing | Dec 17, 2020 | — |
| D/A | Filing | May 15, 2020 | — |
| D | Filing | Nov 19, 2019 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- CARL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Carlsbad, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1794546
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.